Headlands Technologies LLC Legend Biotech Corp Transaction History
Headlands Technologies LLC
- $939 Million
- Q4 2024
A detailed history of Headlands Technologies LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Headlands Technologies LLC holds 11,935 shares of LEGN stock, worth $473,819. This represents 0.04% of its overall portfolio holdings.
Number of Shares
11,935
Previous 562
2023.67%
Holding current value
$473,819
Previous $27,000
1337.04%
% of portfolio
0.04%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
231Shares Held
86MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$298 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$270 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$238 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$227 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$227 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.65B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...